Devyser Diagnostics

93.00 SEK

-0.11 %

Less than 1K followers

DVYSR

First North Stockholm

Medical Equipment & Services

Health Care

-0.11 %
-0.21 %
+3.10 %
-18.56 %
-17.99 %
-9.18 %
+13.41 %
-
+4.49 %

Devyser Diagnostics develops, manufactures, and sells genetic tests to laboratories globally. The products are used for DNA tests in oncology, transplantation, and hereditary diseases to enable tailored cancer treatment, diagnosis of a large number of genetic diseases, and follow-up of transplant patients. The company is headquartered in Hägersten.

Read more
Market cap
1.56B SEK
Turnover
2.9M SEK
Revenue
250.5M
EBIT %
4.03 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20/7
2026

Interim report Q2'26

3/11
2026

Interim report Q3'26

16/2
2027

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.